Mariola Matysiak

1.4k total citations
34 papers, 825 citations indexed

About

Mariola Matysiak is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Mariola Matysiak has authored 34 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 9 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Mariola Matysiak's work include Multiple Sclerosis Research Studies (16 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Immune Response and Inflammation (6 papers). Mariola Matysiak is often cited by papers focused on Multiple Sclerosis Research Studies (16 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Immune Response and Inflammation (6 papers). Mariola Matysiak collaborates with scholars based in Poland, United States and France. Mariola Matysiak's co-authors include Krzysztof Selmaj, Anna Jurewicz, Mariusz Stasiołek, Cedric S. Raine, Krzysztof Tybor, Przemysław Lewkowicz, Natalia Lewkowicz, Hanna Ćwiklińska, Marcin P. Mycko and Patrycja Przygodzka and has published in prestigious journals such as The Journal of Immunology, Brain and Neurology.

In The Last Decade

Mariola Matysiak

32 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariola Matysiak Poland 15 265 251 222 166 121 34 825
Jennifer L. Berard Canada 9 238 0.9× 220 0.9× 321 1.4× 321 1.9× 88 0.7× 9 929
Arianna Merlini Italy 12 337 1.3× 123 0.5× 245 1.1× 187 1.1× 194 1.6× 12 945
Helena S. Domingues Portugal 13 329 1.2× 315 1.3× 406 1.8× 327 2.0× 202 1.7× 17 1.2k
Sandrine Pouly Switzerland 16 344 1.3× 319 1.3× 753 3.4× 212 1.3× 157 1.3× 31 1.4k
Melissa Gresle Australia 17 193 0.7× 242 1.0× 271 1.2× 129 0.8× 104 0.9× 37 773
Bartosz Bielecki Poland 13 177 0.7× 187 0.7× 271 1.2× 188 1.1× 155 1.3× 16 758
Katarzyna Biernacki Canada 15 182 0.7× 255 1.0× 399 1.8× 481 2.9× 76 0.6× 19 1.1k
Camilla Reali Italy 13 206 0.8× 101 0.4× 141 0.6× 159 1.0× 120 1.0× 16 601
Mark Marriott Australia 13 130 0.5× 296 1.2× 207 0.9× 102 0.6× 184 1.5× 28 758
Akira Sugimoto Japan 18 424 1.6× 171 0.7× 274 1.2× 96 0.6× 110 0.9× 61 1.3k

Countries citing papers authored by Mariola Matysiak

Since Specialization
Citations

This map shows the geographic impact of Mariola Matysiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariola Matysiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariola Matysiak more than expected).

Fields of papers citing papers by Mariola Matysiak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariola Matysiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariola Matysiak. The network helps show where Mariola Matysiak may publish in the future.

Co-authorship network of co-authors of Mariola Matysiak

This figure shows the co-authorship network connecting the top 25 collaborators of Mariola Matysiak. A scholar is included among the top collaborators of Mariola Matysiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariola Matysiak. Mariola Matysiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Siwecka, Natalia, et al.. (2025). Sleep Disorders in Neurodegenerative Diseases with Dementia: A Comprehensive Review. Journal of Clinical Medicine. 14(19). 7119–7119.
2.
Szelenberger, Rafał, Leslaw Gorniak, Elżbieta Miller, et al.. (2025). Oxidative DNA Damage and Repair Dynamics in Multiple Sclerosis: Insights from Comet Assay Kinetics, Base Excision Repair Gene Expression, and Genotype Analysis. Biomolecules. 15(6). 756–756. 1 indexed citations
3.
Siger, Małgorzata, et al.. (2025). Brain Atrophy and Cognitive Impairment in Primary and Secondary Progressive Multiple Sclerosis Cohort—Similar Progressive MS Phenotype. International Journal of Molecular Sciences. 26(17). 8523–8523.
4.
Namiecińska, Magdalena, Natalia Lewkowicz, Zbigniew Jabłonowski, et al.. (2024). Histone H3 posttranslational modified enzymes defined neutrophil plasticity and their vulnerability to IL-10 in the course of the inflammation. Journal of Inflammation. 21(1). 16–16. 5 indexed citations
5.
6.
Matysiak, Mariola, et al.. (2022). Effect of Multiple Sclerosis Cerebrospinal Fluid and Oligodendroglia Cell Line Environment on Human Wharton’s Jelly Mesenchymal Stem Cells Secretome. International Journal of Molecular Sciences. 23(4). 2177–2177. 1 indexed citations
7.
Matysiak, Mariola, et al.. (2022). The influence of COVID-19 pandemic lockdown on the physical activity of people with multiple sclerosis. The role of online training. Multiple Sclerosis and Related Disorders. 63. 103843–103843. 11 indexed citations
8.
Namiecińska, Magdalena, Natalia Lewkowicz, Zbigniew Jabłonowski, et al.. (2022). Changes Within H3K4me3-Marked Histone Reveal Molecular Background of Neutrophil Functional Plasticity. Frontiers in Immunology. 13. 906311–906311. 6 indexed citations
9.
Niebudek-Bogusz, Ewa, et al.. (2021). Speech Pathology-Specific Questionnaire for Persons with Multiple Sclerosis (SMS): adaptation, validation and preliminary assessment of the diagnostic potential.. Multiple Sclerosis and Related Disorders. 49. 102796–102796. 6 indexed citations
10.
11.
Stasiołek, Mariusz, et al.. (2020). Cognitive Dysfunction in the Early Stages of Multiple Sclerosis—How Much and How Important?. Current Neurology and Neuroscience Reports. 20(7). 22–22. 57 indexed citations
12.
Namiecińska, Magdalena, Marek Wieczorek, Sylwia Michlewska, et al.. (2019). Multiple Sclerosis CD49d+CD154+ As Myelin-Specific Lymphocytes Induced During Remyelination. Cells. 9(1). 15–15. 14 indexed citations
13.
Stasiołek, Mariusz, et al.. (2019). Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases. Multiple Sclerosis and Related Disorders. 37. 101452–101452. 65 indexed citations
14.
Lewkowicz, Natalia, Marcin P. Mycko, Patrycja Przygodzka, et al.. (2015). Induction of human IL-10-producing neutrophils by LPS-stimulated Treg cells and IL-10. Mucosal Immunology. 9(2). 364–378. 80 indexed citations
15.
Matysiak, Mariola, et al.. (2011). Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2. Journal of Neuroimmunology. 233(1-2). 106–111. 51 indexed citations
16.
Jurewicz, Anna, et al.. (2005). TRAIL‐induced death of human adult oligodendrocytes is mediated by JNK pathway. Glia. 53(2). 158–166. 36 indexed citations
17.
Jurewicz, Anna, et al.. (2005). Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain. 128(11). 2675–2688. 95 indexed citations
18.
Jurewicz, Anna, Mariola Matysiak, Krzysztof Tybor, & Krzysztof Selmaj. (2003). TNF‐induced death of adult human oligodendrocytes is mediated by c‐jun NH2‐terminal kinase‐3. Brain. 126(6). 1358–1370. 58 indexed citations
19.
Matysiak, Mariola. (2002). TRAIL induces death of human oligodendrocytes isolated from adult brain. Brain. 125(11). 2469–2480. 54 indexed citations
20.
Fouin-Fortunet, H, et al.. (1988). The hepatotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats. Cancer Chemotherapy and Pharmacology. 22(2). 153–62. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer L. Berard Breakdown of academic impact, for papers by Arianna Merlini Breakdown of academic impact, for papers by Helena S. Domingues Breakdown of academic impact, for papers by Sandrine Pouly Breakdown of academic impact, for papers by Melissa Gresle Breakdown of academic impact, for papers by Bartosz Bielecki Breakdown of academic impact, for papers by Katarzyna Biernacki Breakdown of academic impact, for papers by Camilla Reali Breakdown of academic impact, for papers by Mark Marriott Breakdown of academic impact, for papers by Akira Sugimoto
Rankless by CCL
2026